The history of copyright's flagship drug presents a interesting case for stakeholders in the medicinal sector. While initially a tremendous success, creating vast sums, the intellectual property expiration and the Gambling subsequent arrival of off-brand versions have significantly changed revenue. This raises questions about the ongoing viability